Published in J Leukoc Biol on December 31, 2008
Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines. J Biol Chem (2015) 0.82
Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes. MAbs (2014) 0.82
The self/nonself issue: A confrontation between proteomes. Self Nonself (2010) 0.79
A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2). MAbs (2014) 0.79
Novel peptide screened from a phage display library antagonizes the activity of CC chemokine receptor 9. Oncol Lett (2017) 0.75
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol (2008) 11.73
Development of a human adaptive immune system in cord blood cell-transplanted mice. Science (2004) 7.07
PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies. Cancer Res (2009) 4.82
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. J Clin Invest (2010) 3.11
Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proc Natl Acad Sci U S A (2006) 3.07
Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol (2007) 2.40
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. Clin Cancer Res (2011) 2.27
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer. PLoS One (2009) 2.18
Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. J Natl Cancer Inst (2006) 1.89
Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J Clin Invest (2009) 1.73
The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol (2012) 1.68
A case of lenalidomide-induced hypersensitivity pneumonitis. Onkologie (2010) 1.50
Risk factors of central nervous system relapse in mantle cell lymphoma. Leuk Lymphoma (2013) 1.49
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors. Clin Cancer Res (2012) 1.49
Acute radiation colitis in patients treated with short-term preoperative radiotherapy for rectal cancer. Am J Surg Pathol (2002) 1.44
Patterns of survival of follicular lymphomas at a single institution through three decades. Leuk Lymphoma (2010) 1.44
ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation in daily practice. J Thorac Oncol (2015) 1.42
Inhibition of natural type I IFN-producing and dendritic cell development by a small molecule receptor tyrosine kinase inhibitor with Flt3 affinity. J Immunol (2005) 1.37
Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. J Immunol (2004) 1.17
Human adaptive immune system Rag2-/-gamma(c)-/- mice. Ann N Y Acad Sci (2005) 1.10
Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.08
Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts. Kidney Int (2003) 1.05
Incidence, risk factors and outcome of histological transformation in follicular lymphoma. Br J Haematol (2012) 1.02
The Bethesda System for reporting thyroid fine-needle aspiration specimens. Am J Clin Pathol (2010) 1.00
Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer. Am J Pathol (2003) 0.97
High expression of peptide receptors as a novel target in gastrointestinal stromal tumours. Eur J Nucl Med Mol Imaging (2004) 0.95
Use of real-time polymerase chain reaction to identify cell- and tissue-type-selective peptides by phage display. Am J Pathol (2003) 0.95
Interaction of ICAM-1 with beta 2-integrin CD11c/CD18: characterization of a peptide ligand that mimics a putative binding site on domain D4 of ICAM-1. Eur J Immunol (2005) 0.94
Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. World J Gastroenterol (2010) 0.93
Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts. J Pathol (2003) 0.93
Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing. J Immunol (2006) 0.89
Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study. Cancer Cytopathol (2011) 0.89
Internal Quality Assurance Program for ERBB2 (HER2) Testing Improves the Selection of Breast Cancer Patients for Treatment with Trastuzumab. Patholog Res Int (2012) 0.88
HER2 in solid tumors: more than 10 years under the microscope; where are we now? Future Oncol (2014) 0.87
Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: A possible link to endometrioid adenocarcinoma. Mod Pathol (2006) 0.86
Epidemiology and molecular biology of gastrointestinal stromal tumors (GISTs): a population-based study in the South of Switzerland, 1999-2005. Histol Histopathol (2008) 0.85
Response to oxaliplatin with cetuximab in minor salivary gland adenoid cystic carcinoma. Tumori (2009) 0.84
Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways. J Pathol (2005) 0.84
Imaging in endocrinology: Langherans cell histiocytosis of the thyroid gland detected by 18FDG-PET/CT. J Clin Endocrinol Metab (2007) 0.83
1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. Kidney Int (2002) 0.83
Rapid-growing left intraventricular cardiac hemangioma. J Am Soc Echocardiogr (2006) 0.83
Simultaneous occurrence of peripheral T-cell lymphoma unspecified and B-cell small lymphocytic lymphoma. Report of 2 cases. Hum Pathol (2007) 0.82
Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas. J Pathol (2002) 0.82
Impact of histopathological diagnosis with ancillary immunohistochemical studies on lung cancer subtypes incidence and survival: a population-based study. J Cancer Epidemiol (2011) 0.82
Efficacy of alemtuzumab and gemcitabine in a patient with enteropathy-type T-cell lymphoma. Br J Haematol (2008) 0.81
Peliosis hepatis in cancer patients mimicking infection and metastases. Onkologie (2009) 0.81
Quality indicators of clinical cancer care (QC3) in colorectal cancer. BMJ Open (2013) 0.80
Hyperthermia preconditioning induces renal heat shock protein expression, improves cold ischemia tolerance, kidney graft function and survival in rats. Nephron (2002) 0.80
Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patients. Leuk Lymphoma (2007) 0.80
Scavenger receptor block as strategy for the identification of bone marrow homing phages by panning in vivo random peptide phage displayed libraries. J Immunol Methods (2002) 0.79
Epithelial neutrophil-activating peptide 78 concentrations are elevated in the peritoneal fluid of women with endometriosis. Fertil Steril (2003) 0.79
A case of Hodgkin lymphoma in a patient with a history of bone pain and an initial diagnosis of chronic osteomyelitis. Tumori (2015) 0.79
Hyperfunctioning solid/trabecular follicular carcinoma of the thyroid gland. J Oncol (2010) 0.78
Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type. Hematol Oncol (2007) 0.78
hCXCR1 and hCXCR2 antagonists derived from combinatorial peptide libraries. Cytokine (2011) 0.77
Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis. Histopathology (2012) 0.76
A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals. Pathobiology (2007) 0.76
Granulomatous hepatitis after intravesical bacillus Calmette-Guérin treatment. Scand J Infect Dis (2010) 0.75
The clinical management in familial adenomatous polyposis deserves continuous monitoring for thyroid carcinoma. BMJ Case Rep (2012) 0.75
The impact of histopathologic diagnosis on the proper management of testis neoplasms. Nat Clin Pract Oncol (2008) 0.75
Selection of peptide ligands binding to the basolateral cell surface of proximal convoluted tubules. Kidney Int (2002) 0.75
An unusual case of systolic murmur and recurrent syncopes. Eur Heart J (2013) 0.75
Images in endocrine pathology: a starry-sky in the thyroid. Endocr Pathol (2012) 0.75
Chemokine CCR3 ligands-binding peptides derived from a random phage-epitope library. Immunol Lett (2012) 0.75
Extranodal NK/T-cell lymphoma with leukaemic presentation. Br J Haematol (2013) 0.75
Extrinsic compression of the pulmonary artery by primary mediastinal large B-cell lymphoma. Br J Haematol (2009) 0.75
Malignant mixed müllerian tumor with an extensive squamous-cell carcinomatous component: a potential pitfall in liquid-based cervical cytology. Acta Cytol (2014) 0.75
SS18-bronchial biphasic synovial sarcoma in an octogenarian with hemothorax. Lung (2014) 0.75
Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence. Melanoma Res (2013) 0.75
Gene translocations in testicular lymphomas. Leuk Lymphoma (2013) 0.75
Random phage-epitope library based identification of a peptide antagonist of Mac-1 β2 integrin ligand binding. Matrix Biol (2011) 0.75